We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+13.63%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$27.1B
AUM Growth
+$1.76B
(+6.9%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-4.45%
Top 10 Holdings %
Top 10 Hldgs %
42.04%
Holding
292
New
14
Increased
41
Reduced
114
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.5M |
| 2 |
RTX Corp
RTX
|
+$44.9M |
| 3 |
Eli Lilly
LLY
|
+$39.2M |
| 4 |
Mastercard
MA
|
+$24.4M |
| 5 |
UnitedHealth
UNH
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$283M |
| 2 |
T. Rowe Price
TROW
|
+$142M |
| 3 |
Apple
AAPL
|
+$73.9M |
| 4 |
Philip Morris
PM
|
+$72.2M |
| 5 |
Chevron
CVX
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.65% |
| 2 | Consumer Staples | 19.62% |
| 3 | Financials | 18.7% |
| 4 | Energy | 13.49% |
| 5 | Healthcare | 12.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AstraZeneca
AZN
$245B
| $1.67M | 0.01% |
+12,348
| New | +$1.55M |
|
152
DuPont de Nemours
DD
$19.1B
| $1.6M | 0.01% |
18,613
+122
| +0.7% | +$9.75K |
|
|
XIFR
153
XPLR Infrastructure LP
XIFR
$1.12B
| $1.55M | 0.01% |
22,134
| – | – |
|
154
Fox Class B
FOX
$22.1B
| $1.49M | 0.01% |
52,430
-12,427
| -19% | -$356K |
|
155
Edwards Lifesciences
EW
$51.1B
| $1.41M | 0.01% |
18,873
| – | – |
|
156
BHP
BHP
$212B
| $1.39M | 0.01% |
22,367
| – | – |
|
|
FISV
157
Fiserv Inc
FISV
$29B
| $1.36M | 0.01% |
13,444
| – | – |
|
158
Freeport-McMoran
FCX
$91.5B
| $1.32M | ﹤0.01% |
34,710
-25,430
| -42% | -$889K |
|
159
Unilever
UL
$137B
| $1.3M | ﹤0.01% |
22,963
-5,956
| -21% | -$319K |
|
160
Kirby Corp
KEX
$6.98B
| $1.3M | ﹤0.01% |
20,195
-2,060
| -9% | -$137K |
|
161
Dow Inc
DOW
$21.6B
| $1.29M | ﹤0.01% |
25,692
+152
| +0.6% | +$7.43K |
|
162
Valero Energy
VLO
$88.5B
| $1.29M | ﹤0.01% |
10,150
+16
| +0.2% | +$2.01K |
|
163
AvalonBay Communities
AVB
$27B
| $1.28M | ﹤0.01% |
7,900
| – | – |
|
164
Invesco QQQ Trust
QQQ
$469B
| $1.26M | ﹤0.01% |
4,745
| – | – |
|
165
Amphenol
APH
$201B
| $1.25M | ﹤0.01% |
32,808
| – | – |
|
166
Waste Management
WM
$90.5B
| $1.2M | ﹤0.01% |
7,637
| – | – |
|
167
Advanced Micro Devices
AMD
$790B
| $1.19M | ﹤0.01% |
18,352
| – | – |
|
|
RETA
168
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.15M | ﹤0.01% |
30,329
| – | – |
|
169
Northrop Grumman
NOC
$77.9B
| $1.13M | ﹤0.01% |
2,069
| – | – |
|
170
Kimberly-Clark
KMB
$35.7B
| $1.08M | ﹤0.01% |
7,964
| – | – |
|
171
Corteva
CTVA
$50.7B
| $1.03M | ﹤0.01% |
17,451
+152
| +0.9% | +$9.62K |
|
172
Bristol-Myers Squibb
BMY
$134B
| $1.01M | ﹤0.01% |
14,064
+782
| +6% | +$59K |
|
173
Coca-Cola Europacific Partners
CCEP
$47.8B
| $996K | ﹤0.01% |
18,000
| – | – |
|
174
Rockwell Automation
ROK
$53.5B
| $986K | ﹤0.01% |
3,829
| – | – |
|
175
Archer Daniels Midland
ADM
$37.6B
| $950K | ﹤0.01% |
10,234
| – | – |
|
Similar funds
HF
Fayez Sarofim & Co's Q4 2022 Portfolio in Review
As of Q4 2022, Fayez Sarofim & Co held 292 positions worth $27.1B, up 6.9% from $25.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Fayez Sarofim & Co withdrew a net $1.21B in Q4 2022, closing 11 positions and reducing 114 holdings. Its most notable exit was Artisan Partners, an estimated $16.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Fayez Sarofim & Co opened a new position in AstraZeneca worth $1.67M.
- Fayez Sarofim & Co's largest Q4 2022 buy was AstraZeneca: 12,348 shares worth $1.67M.
- Fayez Sarofim & Co added most to Visa in Q4 2022, an estimated $56.5M increase.
- Fayez Sarofim & Co's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $283M.
- Fayez Sarofim & Co fully exited Artisan Partners in Q4 2022, selling an estimated $16.2M.
- Fayez Sarofim & Co's ten largest holdings make up 42% of its $27.1B portfolio in Q4 2022.
- Fayez Sarofim & Co opened 14 new positions and closed 11 in Q4 2022.
- Fayez Sarofim & Co's portfolio value rose 6.9% quarter-over-quarter to $27.1B.
Based on Fayez Sarofim & Co's 13F filing for Q4 2022, filed 13 Feb 2023.